Meyer M, Watermann C, Dreyer T, Wagner S, Wittekindt C, Klussmann J
Int J Mol Sci. 2021; 22(15).
PMID: 34360635
PMC: 8345988.
DOI: 10.3390/ijms22157872.
Butovich I
Exp Eye Res. 2017; 163:2-16.
PMID: 28669846
PMC: 5728685.
DOI: 10.1016/j.exer.2017.06.020.
Hofer D, Pessentheiner A, Pelzmann H, Schlager S, Madreiter-Sokolowski C, Kolb D
Biochim Biophys Acta Mol Cell Biol Lipids. 2016; 1862(3):358-368.
PMID: 28017862
PMC: 7116240.
DOI: 10.1016/j.bbalip.2016.12.009.
Govaerts L, Monnens L, Melis T, Trijbels F
Eur J Pediatr. 1984; 143(1):10-2.
PMID: 6096149
DOI: 10.1007/BF00442740.
Barth P, Schutgens R, BAKKEREN J, Dingemans K, Heymans H, Douwes A
Eur J Pediatr. 1985; 144(4):338-42.
PMID: 4076250
DOI: 10.1007/BF00441774.
Disturbed very long chain (C24-C26) fatty acid pattern in fibroblasts of patients with Zellweger's syndrome.
Govaerts L, Bakkeren J, Monnens L, Maas J, Trijbels F, Kleijer W
J Inherit Metab Dis. 1985; 8(1):5-8.
PMID: 3921760
DOI: 10.1007/BF01805473.
Very-long-chain fatty acids from lower organism.
rezanka T, CUDLIN J, PODOJIL M
Folia Microbiol (Praha). 1987; 32(2):149-76.
PMID: 3556353
DOI: 10.1007/BF02883244.
Presence of the peroxisomal 22-kDa integral membrane protein in the liver of a person lacking recognizable peroxisomes (Zellweger syndrome).
Lazarow P, Fujiki Y, SMALL G, Watkins P, Moser H
Proc Natl Acad Sci U S A. 1986; 83(23):9193-6.
PMID: 3538019
PMC: 387101.
DOI: 10.1073/pnas.83.23.9193.
Peroxisomal disorders: a newly recognised group of genetic diseases.
Schutgens R, Heymans H, Wanders R, van den Bosch H, Tager J
Eur J Pediatr. 1986; 144(5):430-40.
PMID: 3514227
DOI: 10.1007/BF00441734.
Localization of pipecolic acid metabolism in rat liver peroxisomes: probable explanation for hyperpipecolataemia in Zellweger syndrome.
Trijbels J, Monnens L, Melis G, van den Broekvan Essen M, Bruckwilder M
J Inherit Metab Dis. 1987; 10(2):128-34.
PMID: 3116331
DOI: 10.1007/BF01800037.
Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy.
Vamecq J, Draye J, Van Hoof F, Misson J, Evrard P, Verellen G
Am J Pathol. 1986; 125(3):524-35.
PMID: 2879480
PMC: 1888479.
Further analysis of the disturbed adrenocortical function in the cerebro-hepato-renal syndrome of Zellweger.
Govaerts L, Sippell W, Monnens L
J Inherit Metab Dis. 1989; 12(4):423-8.
PMID: 2560099
DOI: 10.1007/BF01802037.
Neonatal adrenoleukodystrophy.
Aubourg P, Scotto J, Rocchiccioli F, Robain O
J Neurol Neurosurg Psychiatry. 1986; 49(1):77-86.
PMID: 2420940
PMC: 1028652.
DOI: 10.1136/jnnp.49.1.77.
The inborn errors of peroxisomal beta-oxidation: a review.
Wanders R, van Roermund C, Schutgens R, Barth P, Heymans H, van den Bosch H
J Inherit Metab Dis. 1990; 13(1):4-36.
PMID: 2109148
DOI: 10.1007/BF01799330.
Metabolism of prostaglandin F2 alpha in Zellweger syndrome. Peroxisomal beta-oxidation is a major importance for in vivo degradation of prostaglandins in humans.
Diczfalusy U, Kase B, Alexson S, Bjorkhem I
J Clin Invest. 1991; 88(3):978-84.
PMID: 1885782
PMC: 295499.
DOI: 10.1172/JCI115401.
Linkage analysis in X-linked adrenoleukodystrophy and application in post- and prenatal diagnosis.
van Oost B, van Zandvoort P, Tunte W, Brunner H, Hoogeboom A, Bakkeren J
Hum Genet. 1991; 86(4):404-7.
PMID: 1671851
DOI: 10.1007/BF00201845.
X-linked adrenoleukodystrophy: biochemical diagnosis and enzyme defect.
Wanders R, van Roermund C, Lageweg W, Jakobs B, Schutgens R, Nijenhuis A
J Inherit Metab Dis. 1992; 15(4):634-44.
PMID: 1528022
DOI: 10.1007/BF01799620.
